Investigations for Suspected Cortical Vein Thrombosis
For suspected cortical vein thrombosis, immediately obtain neuroimaging with CT venography or MR venography, along with complete blood count, D-dimer, coagulation screen (PT/aPTT), and fibrinogen level. 1
Initial Laboratory Testing
Essential blood work includes:
- Complete blood count to assess platelet count and identify thrombocytopenia 1
- D-dimer measurement - while a normal D-dimer (using sensitive immunoassay or rapid ELISA) may help identify low-probability cases, an elevated D-dimer is common but non-specific; a normal result should not preclude further evaluation if clinical suspicion remains high 1
- Coagulation screen including prothrombin time (PT) and activated partial thromboplastin time (aPTT) 1
- Clauss fibrinogen assay to assess for consumptive coagulopathy 1
- Blood film to confirm true platelet abnormalities and exclude alternative diagnoses 1
Neuroimaging Studies
Diagnostic imaging is critical and should be performed urgently:
- CT venography or MR venography is recommended as first-line imaging to confirm cortical vein thrombosis 1
- MRI with venography is the standard diagnostic tool and superior for detecting isolated cortical vein thrombosis 1, 2
- Catheter angiography (DSA) should be considered if non-invasive venography is inconclusive but clinical suspicion remains high 1
- Plain CT or MRI may show the "cord sign" (hyperdense thrombosed vein) or associated hemorrhage, but venographic sequences are essential for definitive diagnosis 1
Screening for Underlying Causes
Evaluate for prothrombotic conditions and precipitating factors:
- Vaccination history - particularly recent COVID-19 vaccination to assess for vaccine-induced immune thrombocytopenia and thrombosis (VITT) 1
- Anti-PF4 antibody ELISA if VITT is suspected (thrombocytopenia with D-dimer >2000-4000 μg/mL FEU within 5-30 days of vaccination) 1
- Screen for infections and inflammatory conditions that may predispose to thrombosis 1
- Contraceptive use history and other medication exposures 1
- JAK2 V617F mutation testing should be considered, as myeloproliferative disorders can be found in up to 13% of cerebral venous thrombosis cases 1
Special Considerations
Important caveats in the diagnostic workup:
- D-dimer levels decline with time from symptom onset, so patients with subacute or chronic presentations may have false-negative results 1
- Lumbar puncture is not routinely indicated unless meningitis is suspected; it does not help confirm the diagnosis when imaging is available 1
- Repeat platelet count in 2-3 days if initial count is normal but clinical suspicion remains high, as 5% of VITT patients have initially normal platelets that subsequently fall 1
- Thrombophilia testing (protein C, protein S, antithrombin, factor V Leiden, prothrombin G20210A) is generally not recommended acutely as it rarely alters immediate management and results are affected by acute thrombosis and anticoagulation 3, 4, 5, 6
Timing and Urgency
Same-day imaging is essential when clinical suspicion is high, as cortical vein thrombosis can extend bidirectionally to involve dural sinuses and cause rapid neurological deterioration 1, 2
The diagnostic approach should prioritize rapid confirmation of thrombosis to enable immediate anticoagulation, which is the cornerstone of treatment even in the presence of hemorrhagic transformation 1, 2